Theranostics 2014; 4(8):845-857. doi:10.7150/thno.8343 This issue Cite

Research Paper

MRI of Breast Tumor Initiating Cells Using the Extra Domain-B of Fibronectin Targeting Nanoparticles

Yujin Sun1, 2*, Hoe Suk Kim1*, Jinho Park3*, Mulan Li1, Lianji Tian1, YoonSeok Choi1, Byung Ihn Choi1, Sangyong Jon3✉, Woo Kyung Moon1✉

1. Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea
2. Department of Radiology, Yanbian University Hospital, 1327 JuZi Street, Yanji City, JiLin Province 133000, China
3. KAIST Institute for the BioCentury, Department of Biological Sciences, Korea Advanced Institute of Science and Technology, 291 Daehak-ro, Yuseong-gu, Daejeon 305-701, Korea
*These authors contributed equally to this work.

Citation:
Sun Y, Kim HS, Park J, Li M, Tian L, Choi Y, Choi BI, Jon S, Moon WK. MRI of Breast Tumor Initiating Cells Using the Extra Domain-B of Fibronectin Targeting Nanoparticles. Theranostics 2014; 4(8):845-857. doi:10.7150/thno.8343. https://www.thno.org/v04p0845.htm
Other styles

File import instruction

Abstract

The identification of breast tumor initiating cells (BTICs) is important for the diagnosis and therapy of breast cancers. This study was undertaken to evaluate whether the extra domain-B of fibronectin (EDB-FN) could be used as a new biomarker for BTICs and whether EDB-FN targeting superparamagnetic iron oxide nanoparticles (SPIONs) could be used as a magnetic resonance imaging (MRI) contrast agent for BTIC imaging in vitro and in vivo. BTICs (NDY-1) exhibited high EDB-FN expression, whereas non-BTICs (MCF-7, BT-474, SUM-225, MDA-MB-231) did not exhibit EDB-FN expression. Furthermore, Cy3.3-labeled EDB-FN specific peptides (APTEDB) showed preferential binding to the targeted NDY-1 cells. To construct an EDB-FN targeted imaging probe, APTEDB was covalently attached to a thermally cross-linked SPION (TCL-SPION) to yield APTEDB-TCL-SPION. In the in vitro MRI of cell phantoms, selective binding of APTEDB-TCL-SPION to NDY-1 cells was evident, but little binding was observed in MCF-7 cells. After the intravenous injection of APTEDB-TCL-SPION into the NDY-1 mouse tumor xenograft model, a significant decrease in the signal within the tumor was observed in the T2*-weighted images; however, there was only a marginal change in the signal of non-targeting SPIONs such as APTscramble-TCL-SPION or TCL-SPION. Taken together, we report for the first time that EDB-FN was abundantly expressed in BTICs and may therefore be useful as a new biomarker for identifying BTICs. Our study also suggests that APTEDB-TCL-SPION could be used as an MRI contrast agent for BTIC imaging.

Keywords: Breast tumor initiating cells, Extra domain-B of fibronectin, Aptides, Superparamagnetic iron oxide nanoparticles, Magnetic resonance imaging.


Citation styles

APA
Sun, Y., Kim, H.S., Park, J., Li, M., Tian, L., Choi, Y., Choi, B.I., Jon, S., Moon, W.K. (2014). MRI of Breast Tumor Initiating Cells Using the Extra Domain-B of Fibronectin Targeting Nanoparticles. Theranostics, 4(8), 845-857. https://doi.org/10.7150/thno.8343.

ACS
Sun, Y.; Kim, H.S.; Park, J.; Li, M.; Tian, L.; Choi, Y.; Choi, B.I.; Jon, S.; Moon, W.K. MRI of Breast Tumor Initiating Cells Using the Extra Domain-B of Fibronectin Targeting Nanoparticles. Theranostics 2014, 4 (8), 845-857. DOI: 10.7150/thno.8343.

NLM
Sun Y, Kim HS, Park J, Li M, Tian L, Choi Y, Choi BI, Jon S, Moon WK. MRI of Breast Tumor Initiating Cells Using the Extra Domain-B of Fibronectin Targeting Nanoparticles. Theranostics 2014; 4(8):845-857. doi:10.7150/thno.8343. https://www.thno.org/v04p0845.htm

CSE
Sun Y, Kim HS, Park J, Li M, Tian L, Choi Y, Choi BI, Jon S, Moon WK. 2014. MRI of Breast Tumor Initiating Cells Using the Extra Domain-B of Fibronectin Targeting Nanoparticles. Theranostics. 4(8):845-857.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image